Parenteral application of NADH in Parkinson's disease: Clinical improvement partially due to stimulation of endogenous levodopa biosynthesis

Journal of Neural Transmission

Volumn 103, Issue 10, 1996, Pages 1187-1193

  Kuhn, W ^a,c   Muller Th ^a   Winkel, R ^a   Danielczik, S ^a   Gerstner, A ^a   Hacker R ^b   Mattern, C ^b   Przuntek, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Mattern et Partner   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Endogenous biosynthesis of levodopa; NADH; Parkinson's disease

Indexed keywords

DOPAMINE; LEVODOPA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE;

ADULT; AGED; ANTIPARKINSON AGENTS; BIOLOGICAL AVAILABILITY; DIHYDROPTERIDINE REDUCTASE; ENZYME ACTIVATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEVODOPA; MALE; MIDDLE AGED; NAD; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TYROSINE 3-MONOOXYGENASE;

EID: 0029801686     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271203     Document Type: Article

References (13)

1. Birkmayer GJ, Birkmayer W (1989) Stimulation of endogenous L-dopa biosynthesis - a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide-phosphate (NADPH). Acta Neurol Scand [Suppl 126]: 183-187
2. Birkmayer JG, Vrecko C, Volc D, Birkmayer W (1993) Nicotinamide adenine dinucleotide (NADH) - a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application. Acta Neurol Scand [Suppl 146]: 32-35
3. Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta B, Ott E (1989) The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients. J Neural Transm [PD Sect] 1: 297-302
4. Birkmayer W, Birkmayer JG, Vrecko K, Paletta B (1990) The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients. Adv Neurol 53: 545-549
5. Dizdar N, Kagedal B, Lindvall B (1994) Treatment of Parkinson's disease with NADH. Acta Neurol Scand 90: 345-347
6. Gerlach M, Klaunzer N, Przuntek H (1986) Determination of L-Dopa and 3-O-methyldopa in human plasma by extraction using C18-cartridges followed by high-performance liquid chromatographic analysis with electochemical detection. J Chromatogr 380: 379-385
7. Iuvone PM, Reinhard JF, Jr, Abou Donia MM, Viveros OH, Nichol CA (1985) Stimulation of retinal dopamine biosynthesis in vivo by exogenous tetrahydrobiopterin: relationship to tyrosine hydroxylase activation. Brain Res 359: 392-396
8. Leeming RJ, Blair JA, Melikian V (1983) Intestinal absorption of tetrahydrobiopterin and biopterin in man. Biochem Med 30: 328-332
9. Mattern C (1995) Zur Entwicklung von stabilen Arzneiformen des Coenzyms NADH für die perorale und parenterale Applikation. Humboldt-Universität, Berlin
10. Nichol CA, Smith GK, Duch DS (1985) Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu Rev Biochem 54: 729-764
11. Rausch WD, Hirata Y, Nagatsu T, Riederer P, Jellinger K (1988) Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents. J Neurochem 50: 202-208
12. Uitti RJ, Calne DB (1993) Pathogenesis of idiopathic parkinsonism. Eur Neurol 33 [Suppl 1]: 6-23
13. Vrecko K, Birkmayer JG, Krainz J (1993) Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adenine-dinucleotide (NADH). J Neural Transm [PD Sect] 5: 147-156